RU95102184A - Method of syndrome treatment after the total ovariectomy - Google Patents

Method of syndrome treatment after the total ovariectomy

Info

Publication number
RU95102184A
RU95102184A RU95102184/14A RU95102184A RU95102184A RU 95102184 A RU95102184 A RU 95102184A RU 95102184/14 A RU95102184/14 A RU 95102184/14A RU 95102184 A RU95102184 A RU 95102184A RU 95102184 A RU95102184 A RU 95102184A
Authority
RU
Russia
Prior art keywords
total
ovariectomy
syndrome treatment
syndrome
organs
Prior art date
Application number
RU95102184/14A
Other languages
Russian (ru)
Inventor
З.М. Алиханова
Ru]
В.И. Кулаков
Юджин Майкл Молнар
Г.Т. Сухих
Us]
Original Assignee
Научный центр акушерства
Научный центр акушерства, гинекологии и перинатологии РАМН
гинекологии и перинатологии РАМН (RU)
Международный институт биологической медицины
Международный институт биологической медицины (RU)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научный центр акушерства, Научный центр акушерства, гинекологии и перинатологии РАМН, гинекологии и перинатологии РАМН (RU), Международный институт биологической медицины, Международный институт биологической медицины (RU) filed Critical Научный центр акушерства
Priority to RU95102184/14A priority Critical patent/RU95102184A/en
Publication of RU95102184A publication Critical patent/RU95102184A/en

Links

Abstract

FIELD: medicine, gynecology. SUBSTANCE: method of syndrome therapy after the total ovariectomy involves administration of organs and tissues homogenate prepared of nonviable fetuses. EFFECT: elimination of by-side effects observed at the known method.

Claims (1)

Предложен способ терапии синдрома после тотальной оварэктомии, заключающийся в том, что пациенткам вводят гомогенизированную смесь органов и тканей нежизнеспособных плодов. Способ позволяет исключить побочные эффекты.A method for treating the syndrome after total ovarectomy is proposed, which consists in administering to patients a homogenized mixture of organs and tissues of non-viable fetuses. The method eliminates side effects.
RU95102184/14A 1995-02-15 1995-02-15 Method of syndrome treatment after the total ovariectomy RU95102184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95102184/14A RU95102184A (en) 1995-02-15 1995-02-15 Method of syndrome treatment after the total ovariectomy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95102184/14A RU95102184A (en) 1995-02-15 1995-02-15 Method of syndrome treatment after the total ovariectomy

Publications (1)

Publication Number Publication Date
RU95102184A true RU95102184A (en) 1997-01-20

Family

ID=48432909

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95102184/14A RU95102184A (en) 1995-02-15 1995-02-15 Method of syndrome treatment after the total ovariectomy

Country Status (1)

Country Link
RU (1) RU95102184A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035464A1 (en) * 1998-12-16 2000-06-22 Tsentr Embrionalnykh Tkanei 'emcell' Method for treating patients using cellular suspensions of embryonic tissues

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035464A1 (en) * 1998-12-16 2000-06-22 Tsentr Embrionalnykh Tkanei 'emcell' Method for treating patients using cellular suspensions of embryonic tissues

Similar Documents

Publication Publication Date Title
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
NO165675C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE VINYLPHENOL DERIVATIVES.
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
BG60253B1 (en) HUMAN TISSUE PLASMINOGENIC ACTIVATOR
DE3852640D1 (en) DEVICE FOR ELECTROSTIMULATION.
DE59600683D1 (en) Use of trospium chloride in the manufacture of a medicament for the treatment of bladder diseases
TR199801184T2 (en) New compounds with analgesic action.
RU95102184A (en) Method of syndrome treatment after the total ovariectomy
KR890000108A (en) Pharmaceutical composition for the treatment of tumor
PT862454E (en) NEW USES OF MAMIFERO CTLA-8 AND RELATED REAGENTS
RU95102200A (en) Method of climacteric syndrome treatment
ATE207353T1 (en) USE OF BENZYDAMINE TO TREAT MEDICAL CONDITIONS CAUSED BY TNF
RU2144364C1 (en) Method of treatment of patient with limb lymphedema
RU94007884A (en) Method for adjusting functional state of organism
RU94006477A (en) Method of prophylaxis and treatment of chronic inflammatory diseases in otorhinolaryngology
RU94039356A (en) Method and preparation for treating the cases of hypogalactia
RU94022724A (en) Method for treatment of chronic tonsillitis in children
RU94001389A (en) Method of psoriasis treatment
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU95105265A (en) Agent for treatment of trophic ulcers and burns in patients with leprosy
RU94039553A (en) Agent for chronic prostatitis treatment
Knowles Diseases of the Skin: Including the Acute Eruptive Fevers
RU95102066A (en) Naffziger's syndrome treatment method
DE69724228D1 (en) COMBINATION THERAPY OF TOPOISOMERASE II TOXINES AND BIS-DIOXYPIPERAZINE DERIVATIVES
RU94045660A (en) Method for selecting medicinal complexes-modules for treatment of diseases in humans